Transcriptomics

Dataset Information

0

Characterizing the molecular changes of Basal Cell Carcinoma during vismodegib treatment

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE116966 | GEO | 2018/08/08

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Characterizing the molecular changes of Basal Cell Carcinoma during vismodegib treatment
| PRJNA480702 | ENA
Unknown Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.
| S-EPMC8093898 | biostudies-literature
Unknown Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond.
| S-EPMC3680638 | biostudies-literature
Unknown Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
| S-EPMC5278761 | biostudies-literature
Unknown Investigational agents in metastatic basal cell carcinoma: focus on vismodegib.
| S-EPMC4863308 | biostudies-literature
Unknown Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.
| S-EPMC11193564 | biostudies-literature
Unknown Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.
| S-EPMC5528667 | biostudies-literature
Unknown Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma.
| S-EPMC3777384 | biostudies-literature
Unknown New developments in the treatment of basal cell carcinoma: update on current and emerging treatment options with a focus on vismodegib.
| S-EPMC6267762 | biostudies-literature
Transcriptomics Basal progenitors during cortical neurogenesis
2014-05-01 | E-GEOD-45451 | biostudies-arrayexpress